Vita-Lea® With Iron
Natural health product licensed in Canada
- Licence holder
- Shaklee Canada Inc.
- NPN or DIN-HM
- 80110737
- Status
- Active licence
- Licence date
- 16 June 2021
- Revision date
- 12 October 2023
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bêta-carotène tout trans Source : bêta-carotène | 3,500 UI | Not calculated |
| Bêta-carotène tout trans Source : bêta-carotène | 2,100 mcg | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 0.5 mg | Not calculated |
| Phosphore Source : Dicalcium phosphate dihydrate | 175 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 100 mg | Not calculated |
| Zinc Source : Gluconate de zinc | 7.5 mg | Not calculated |
| Folate Source : Acide folique | 300 mcg | Not calculated |
| Vitamine C Source : Acide ascorbique | 60 mg | Not calculated |
| Vitamine K1 Source : Vitamine K1 | 60 mcg | Not calculated |
| Silicium Source : Dioxyde de silicium | 5.5 mg | Not calculated |
| Fer Source : Fumarate de fer (II) | 9 mg | Not calculated |
| Calcium Source : Dicalcium phosphate dihydrate | 225 mg | Not calculated |
| Biotine Source : Biotine | 150 mcg | Not calculated |
| Molybdène Source : Molybdate de sodium (VI) | 37.5 mcg | Not calculated |
Non-medicinal ingredients
Son de riz, Stéarate de magnésium, Mélange de concentré de tocophérols, Bitartrate de choline, Bioflavonoïdes d'agrumes, Poudre de feuille de luzerne, Extrait de fruit de Malpighia Glabra (Acérola), Hespéridine, Mannitol, Spirulina platensis, entière, NA, Cellulose microcristalline, Croscarmellose de sodium, Hypromellose, Extrait de fruits de l'églantier, Isolat de protéine de pois, Inositol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps to support normal early fetal development (brain and spinal cord). Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80110737
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging